Start an analysis for ANGO
AngioDynamics, Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $15m | 31-Aug-26 | 10-Q filed 08-Oct-26 |
| Remaining authorization | $0 | 31-Aug-26 | 10-Q filed 08-Oct-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | Not found in filings | — | |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 16-Jul-24 | $15m | $0 | n/a | On July 16, 2024, the Board of Directors approved a share repurchase program (the "Repurchase Program") under which they authorized the Company the option to repurchase up to $ 15.0 million of its outstanding common stock.10-Q filed 08-Oct-26 |
Open-market repurchases
None reported in the filings we hold.